Redhill Drug Patent Portfolio

Redhill owns 2 orange book drugs protected by 11 US patents Given below is the list of Redhill's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11878011 Method for eradicating Helicobacter pylori infection in patients regardless of body mass index 27 May, 2042
Active
US10238606 Pharmaceutical compositions for the treatment of Helicobacter pylori 12 Feb, 2034
Active
US11135172 Rifabutin-based compositions and methods for treating Helicobacter pylori infection 12 Feb, 2034
Active
US11931463 All-in-one fixed-dose combination for treating Helicobacter pylori infection 12 Feb, 2034
Active
US9050263 Pharmaceutical compositions for the treatment of Helicobacter pylori 12 Feb, 2034
Active
US9498445 Pharmaceutical compositions for the treatment of Helicobacter pylori 12 Feb, 2034
Active
US9603806 Pharmaceutical compositions for the treatment of Helicobacter pylori 12 Feb, 2034
Active
US8263120 Oral antimicrobial pharmaceutical compositions 03 May, 2025
Active
US8486446 Oral antimicrobial pharmaceutical compositions 03 May, 2025
Active
US8529945 Oral antimicrobial pharmaceutical compositions 03 May, 2025
Active
US8741948 Oral antimicrobial pharmaceutical compositions 03 May, 2025
Active


Given below is the list of recent legal activities going on the following drug patents of Redhill.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 08 May, 2024 US9498445
Mail Patent eGrant Notification 19 Mar, 2024 US11931463
Recordation of Patent Grant Mailed 19 Mar, 2024 US11931463
Recordation of Patent eGrant 19 Mar, 2024 US11931463
Patent eGrant Notification 19 Mar, 2024 US11931463
Email Notification 19 Mar, 2024 US11931463
Patent Issue Date Used in PTA Calculation 19 Mar, 2024 US11931463
Email Notification 29 Feb, 2024 US11931463
Issue Notification Mailed 28 Feb, 2024 US11931463
Payment of Maintenance Fee, 12th Year, Large Entity 13 Feb, 2024 US8263120
Dispatch to FDC 09 Feb, 2024 US11931463
Application Is Considered Ready for Issue 09 Feb, 2024 US11931463
Issue Fee Payment Received 08 Feb, 2024 US11931463
Issue Fee Payment Verified 08 Feb, 2024 US11931463
Email Notification 23 Jan, 2024 US11878011


Redhill's Family Patents

Redhill drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 28.6% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Redhill Drug List

Given below is the complete list of Redhill's drugs and the patents protecting them.


1. Aemcolo

Aemcolo is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8263120 Oral antimicrobial pharmaceutical compositions 03 May, 2025
(6 months from now)
Active
US8486446 Oral antimicrobial pharmaceutical compositions 03 May, 2025
(6 months from now)
Active
US8529945 Oral antimicrobial pharmaceutical compositions 03 May, 2025
(6 months from now)
Active
US8741948 Oral antimicrobial pharmaceutical compositions 03 May, 2025
(6 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aemcolo's drug page


2. Talicia

Talicia is protected by 7 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11878011 Method for eradicating Helicobacter pylori infection in patients regardless of body mass index 27 May, 2042
(17 years from now)
Active
US10238606 Pharmaceutical compositions for the treatment of Helicobacter pylori 12 Feb, 2034
(9 years from now)
Active
US11135172 Rifabutin-based compositions and methods for treating Helicobacter pylori infection 12 Feb, 2034
(9 years from now)
Active
US11931463 All-in-one fixed-dose combination for treating Helicobacter pylori infection 12 Feb, 2034
(9 years from now)
Active
US9050263 Pharmaceutical compositions for the treatment of Helicobacter pylori 12 Feb, 2034
(9 years from now)
Active
US9498445 Pharmaceutical compositions for the treatment of Helicobacter pylori 12 Feb, 2034
(9 years from now)
Active
US9603806 Pharmaceutical compositions for the treatment of Helicobacter pylori 12 Feb, 2034
(9 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Talicia's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List